Gait Rehabilitation to Treat FastOA

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-35
SponsorUniversity of North Carolina, Chapel Hill

About this trial

The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have completed all other formal physical therapy

Are between the ages of 16 and 35

Underwent an anterior cruciate ligament reconstruction (ACLR) between 6 and 60 months prior to enrollment

Demonstrate underloading during gait (vGRF- impact peak <1.12 x BW)

Disqualifiers

A multiple ligament surgery (i.e., PCL)

A lower extremity fracture (i.e., displaced tibial plateau fracture)

Knee osteoarthritis

Trial design

Design model

Crossover

Treatments tested in this trial

  • Real-time gait biofeedback

    Behavioral

    The RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 5th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.

  • Sham real-time gait biofeedback

    Behavioral

    The Sham RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 5th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Real-time gait biofeedback (RTGBF)Active comparator 1 intervention
Group B: Sham real-time gait biofeedback (Sham RTGBF)Sham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Mean Change from Baseline to Week 6 in Vertical Ground Reaction Force

Participants walk on a dual-belt force-sensing treadmill for 3000 steps while vertical ground reaction forces are collected. Change score (Post-Pre) loading rate calculated as the peak of the first time derivative of the vertical ground reaction force time series curve during the first 50% of the stance phase. This will be collected at Baseline (pre-intervention) and 6 weeks posttest. An increase in vertical ground reaction force at 6 weeks from baseline indicates improved gait mechanics.

Time frame
Baseline, Week 6
2

Mean Change from Baseline to Month 6 in Vertical Ground Reaction Force

Participants walk on a dual-belt force-sensing treadmill for 3000 steps while vertical ground reaction forces are collected. Change score (Post-Pre) loading rate calculated as the peak of the first time derivative of the vertical ground reaction force time series curve during the first 50% of the stance phase. This will be collected at Baseline (pre-intervention) and 6 months posttest. An increase in vertical ground reaction force at 6 months from baseline indicates improved gait mechanics.

Time frame
Baseline, Month 6
3

Mean Change from Baseline to Week 6 in Knee Joint Contact Forces

Participants walked on a dual-belt force-sensing treadmill for 3000 steps while lower limb kinematics and kinetics were collected. Walking kinematics and kinetics are submitted to musculoskeletal modeling simulations used to determine the magnitude and location of knee joint contact forces. Change score (post-pre) joint contact forces during the first 50% of the stance phase will be calculated. This will be collected at Baseline (pre-intervention) and 6 weeks posttest. An increase in vertical ground reaction force at 6 weeks from baseline indicates improved gait mechanics.

Time frame
Baseline, Week 6
4

Mean Change from Baseline to Month 6 in Knee Joint Contact Forces

Participants walked on a dual-belt force-sensing treadmill for 3000 steps while lower limb kinematics and kinetics were collected. Walking kinematics and kinetics are submitted to musculoskeletal modeling simulations used to determine the magnitude and location of knee joint contact forces. Change score (post-pre) joint contact forces during the first 50% of the stance phase will be calculated. This will be collected at Baseline (pre-intervention) and 6 months posttest. An increase in vertical ground reaction force at 6 months from baseline indicates improved gait mechanics.

Time frame
Baseline, Month 6

Secondary outcomes

1

Change in the International Knee Documentation Committee Subjective Knee Evaluation Form Score

The International Knee Documentation Committee (IKDC) Subjective Knee Evaluation form is a 10-item survey that determines patient-reported knee-related function. This will be collected at Baseline (pre-intervention), 6-week posttest, and 6-month posttest. A higher score indicates better knee function. Range: 0-100.

Time frame
Up to 6 months
2

Change in the Tegner Activity Scale Score

The Tegner Activity Scale (TAS) to quantify activity levels in individuals with ACL injury on an 11-point Likert scale. A higher score indicates a higher level of activity (e.g., a 10 indicates participants compete in professional or collegiate levels of sport on a regular basis while a 0 indicates indicates that participants are unable to complete any sport or recreational activity due to disability). This will be collected at Baseline (pre-intervention), 6-week posttest, and 6-month posttest.

Time frame
Up to 6 months
3

Change in the Anterior Cruciate Ligament Return to Sport After Injury Scale Score

The Anterior Cruciate Ligament Return to Sport After Injury (ACL-RSI) scale to measure an individual's psychological readiness to return to sport. Range: 0-100 points. A lower score on this questionnaire indicates poorer psychological readiness. This will be collected at Baseline (pre-intervention), 6-week posttest, and 6-month posttest.

Time frame
Up to 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.